Fentanyl-Induced Wooden Chest Syndrome Masquerading as Severe Respiratory Distress Syndrome in COVID-19 by Judd, Grace et al.
Providence St. Joseph Health 
Providence St. Joseph Health Digital Commons 
Providence Portland Medical Center Internal 
Medicine 2021 
Providence Portland Medical Center Internal 
Medicine 
5-2021 
Fentanyl-Induced Wooden Chest Syndrome Masquerading as 




Follow this and additional works at: https://digitalcommons.psjhealth.org/oaa_ppmc_21 
 Part of the Internal Medicine Commons 
Fentanyl-Induced Wooden Chest Syndrome Masquerading as Severe 
Respiratory Distress Syndrome in COVID-19
Grace Judd BS, Rachael Starcher MD, David Hotchkin MD






• 47 yo M with no PMH presented with fever and respiratory distress
• Admitted for COVID-19 pneumonia
Hospital Course
• Intubated for moderate acute respiratory distress syndrome 
(ARDS) on hospital day 11
• Fentanyl infusion started
• Hypoxia improved within 36 hrs but plateau pressures consistently 
>30 cm H2O despite minimizing dead space
• Trial of airway pressure release ventilation worsened hypercarbia
• Bronchoscopy w/o mucous plugging, airway collapse, or purulent 
secretions
• Lung compliance worsened (Pplat=50 on 4 cc/kg) w/o change in 
oxygenation
• Developed suspicion for wooden chest syndrome (WCS) and
discontinued fentanyl
Outcome
• Pplat nadired at 16 within one hour after stopping fentanyl
• Pt successfully extubated on VD 10
Fentanyl uniquely activates laryngeal and respiratory muscle 
potentially leading to a fatal syndrome known as Wooden Chest 
Syndrome (WCS) manifested by poor ventilation
• It is likely more common than clinicians realize
Implications in practice:
• Maintain a high index of suspicion for alternate or overlying 
physiologies when treating persistent ventilatory failure in ARDS 
in COVID-19
Recommendation:
• Discontinue fentanyl if lung compliance and ventilatory failure 
seem out of proportion to hypoxia

























Frequency of UseFrequency of Opiates Used in ICU†
Fentanyl is the most used analgesia 
in ICU patients on mechanical 
ventilation
99%♦ of people develop at least mild 
muscle rigidity when given fentanyl
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Plateau pressure High High
Lung compliance Low Low
Alveolar pressure High Low







c = lung compliance
v = volume
pav = alveolar pressure
ppl = pleural pressure
Low Lung Compliance with Worsening Ventilation
Poor Compliance in both ARDS and WCS
